Day One Biopharmaceuticals, Inc. (DAWN)
8.425
-0.08
(-1.00%)
USD |
NASDAQ |
Dec 11, 16:00
8.425
0.00 (0.00%)
After-Hours: 20:00
Day One Biopharmaceuticals Research and Development Expense (Quarterly): 31.42M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Mersana Therapeutics, Inc. | 12.07M |
| Iovance Biotherapeutics, Inc. | 75.17M |
| Lantheus Holdings, Inc. | 48.02M |
| iRhythm Technologies, Inc. | 21.03M |
| Perspective Therapeutics, Inc. | 19.56M |